Download PDF
Radiologie up2date 2020; 20(03): 235-248
DOI: 10.1055/a-1263-9322
Interventionelle Radiologie

Die Prostataarterienembolisation zur Behandlung des benignen Prostatasyndroms

Prostatic Artery Embolization as Treatment for Benign Prostatic Hyperplasia
Alexander Maßmann
,
Arno Bücker
,
Michael Stöckle
,
Christina Niklas
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Zusammenfassung

Die Prostataarterienembolisation (PAE) ist ein neuartiges Verfahren zur Therapie des benignen Prostatasyndroms (BPS). Die Etablierung des Verfahrens basiert im Wesentlichen auf dem minimalinvasiven Charakter und der klinisch nachweisbaren Verbesserung der Lebensqualität durch Reduktion der alltäglichen und insbesondere nächtlichen BPS-Symptomatik.

Abstract

Prostatic artery embolisation (PAE) has been adopted as a new treatment option for benign prostatic enlargement. The emerging use is based on its minimal-invasive character using a percutaneous approach via the transarterial route combined with improvement of quality of life and clinically proven reduction of life-style compromising benign prostatic syndrome (BPS) related symptoms.

Kernaussagen

  • Die Prostataarterienembolisation ist ein minimalinvasives Verfahren, das mit einer geringen Nebenwirkungsrate assoziiert ist.

  • Erste verfügbare Vergleichsstudien zeigen, dass das Verfahren eine hohe klinische Effektivität aufweist, die sich nach mehreren Wochen einstellt. Allerdings ist der Effekt geringer ausgeprägt als bei der TURP, dem urologisch-operativen Referenzverfahren bei Behandlung einer mittelgroßen Prostata bis ca. 80 ml Volumen. Der Stellenwert wird zwischen den beiden etablierten Säulen der medikamentösen und operativen Therapie gesehen.

  • Durch die PAE werden weitere Verfahren in ihrer Durchführung nicht beeinträchtigt. Durch die Erweiterung des Therapiespektrums ist eine personalisierte, individuell auf den Wunsch des Patienten abgestimmte Behandlung des BPS möglich.

  • Grundsätzlich ist eine interdisziplinäre Kooperation zwischen Urologie und Interventioneller Radiologie empfehlenswert, um zum einen die korrekte Diagnose eines BPS und andererseits die Erfolgsaussichten und potenziellen Risiken der Prostataembolisation kompetent vermitteln zu können.

Schlüsselwörter

Prostata - Prostataembolisation - benignes Prostatasyndrom

Key words

prostate - prostatic artery embolization - benign prostatic hyperplasia


Publication History

Article published online:
15 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Barry MJ, Fowler FJ, Oʼleary MP. et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 2017; 197: S189-S197
    CrossrefPubMedGoogle Scholar
  • 2 Rosen RC, Riley A, Wagner G. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830
    CrossrefPubMedGoogle Scholar
  • 3 DeWitt-Foy ME, Gill BC, Ulchaker JC. Cost Comparison of Benign Prostatic Hyperplasia Treatment Options. Curr Urol Rep 2019; 20: 45
    CrossrefPubMedGoogle Scholar
  • 4 Gill BC, Ulchaker JC. Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room. Curr Urol Rep 2018; 19: 72
    CrossrefPubMedGoogle Scholar
  • 5 Gravas S, Cornu JN, Gacci M. et al. EAU Guidelines. Edn. Management of Non-neurogenic Male LUTS. Presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-07-3. 2020.
    PubMedGoogle Scholar
  • 6 Quirk M, Srinivasa RN, McWilliams JP. et al. Carbon Dioxide Angiography for Prostatic Artery Embolization in a Patient with Massive Prostatomegaly and Chronic Kidney Disease. J Vasc Interv Radiol 2019; 30: 1637-1639
    CrossrefPubMedGoogle Scholar
  • 7 Schott P, Katoh M, Fischer N. et al. Radiation Dose in Prostatic Artery Embolization Using Cone-Beam CT and 3D Roadmap Software. J Vasc Interv Radiol 2019; 30: 1452-1458
    CrossrefPubMedGoogle Scholar
  • 8 Wang MQ, Duan F, Yuan K. et al. Benign Prostatic Hyperplasia: Cone-Beam CT in Conjunction with DSA for Identifying Prostatic Arterial Anatomy. Radiology 2017; 282: 271-280
    CrossrefPubMedGoogle Scholar
  • 9 Andrade G, Khoury HJ, Garzón WJ. et al. Radiation Exposure of Patients and Interventional Radiologists during Prostatic Artery Embolization: A Prospective Single-Operator Study. J Vasc Interv Radiol 2017; 28: 517-521
    CrossrefPubMedGoogle Scholar
  • 10 Ayyagari R, Powell T, Staib L. et al. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia. J Vasc Interv Radiol 2019; 30: 1459-1470
    CrossrefPubMedGoogle Scholar
  • 11 Bilhim T, Costa NV, Torres D. et al. Randomized Clinical Trial of Balloon Occlusion versus Conventional Microcatheter Prostatic Artery Embolization for Benign Prostatic Hyperplasia. J Vasc Interv Radiol 2019; 30: 1798-1806
    CrossrefPubMedGoogle Scholar
  • 12 Carnevale FC, Antunes AA, da Motta Leal Filho JM. et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 2010; 33: 355-361
    CrossrefPubMedGoogle Scholar
  • 13 Pisco JM, Pinheiro LC, Bilhim T. et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 2011; 22: 11-19 quiz 20
    CrossrefPubMedGoogle Scholar
  • 14 Pisco JM, Bilhim T, Pinheiro LC. et al. Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients. J Vasc Interv Radiol 2016; 27: 1115-1122
    CrossrefPubMedGoogle Scholar
  • 15 Kurbatov D, Russo GI, Lepetukhin A. et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology 2014; 84: 400-404
    CrossrefPubMedGoogle Scholar
  • 16 Russo GI, Kurbatov D, Sansalone S. et al. Prostatic Arterial Embolization vs. Open Prostatectomy: A 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities. Urology 2015; 86: 343-348
    CrossrefPubMedGoogle Scholar
  • 17 Abt D, Hechelhammer L, Müllhaupt G. et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ 2018; 361: k2338
    CrossrefPubMedGoogle Scholar
  • 18 Ray AF, Powell J, Speakman MJ. et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 2018; 122: 270-282
    CrossrefPubMedGoogle Scholar
  • 19 Insausti I, Sáez de Ocáriz A, Galbete A. et al. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia. J Vasc Interv Radiol 2020; 31: 882-890 doi:10.1016/j.jvir.2019.12.810
    CrossrefPubMedGoogle Scholar
  • 20 Zumstein V, Betschart P, Vetterlein MW. et al. Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. Eur Urol Focus 2019; 5: 1091-1100
    CrossrefPubMedGoogle Scholar
  • 21 Carnevale FC, Iscaife A, Yoshinaga EM. et al. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol 2016; 39: 44-52
    CrossrefPubMedGoogle Scholar
  • 22 Malling B, Røder MA, Brasso K. et al. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol 2019; 29: 287-298
    CrossrefPubMedGoogle Scholar